To evaluate the possible effect of two leading soft contact lens care products on corneal sensitivity, relative comfort, and superficial corneal staining in adapted disposable soft contact lens wearers. Methods. Eight disposable soft contact lens wearers equally divided between habitual users of OPTI-FREE Express Lasting Comfort No Rub formula (Alcon Laboratories, Fort Worth, TX) and ReNu MultiPlus (Bausch & Lomb, Rochester, NY) were enrolled in this crossover study. The habitual lens care product was designated the first crossover period. Patients completed a visual analog scale rating of midday and end-of-day comfort, underwent slitlamp examination for staining, and had corneal sensitivity measured by Cochet-Bonnet esthesiometry before and after being switched to the alternative lens care product. The lens care product used was masked from the investigator. Results. Patients habitually using OPTI-FREE Express reported higher comfort ratings than did patients using ReNu MultiPlus. On crossover, patients who initially used ReNu MultiPlus experienced similar comfort when using OPTI-FREE Express, but OPTI-FREE Express users experienced a substantial decrease in comfort when switched to ReNu MultiPlus. Esthesiometry showed significant differences in average sensitivity in favor of OPTI-FREE Express (Pϭ0.0041). Statistical trends supported observed increases in corneal sensitivity when switching to OPTI-FREE Express and decreased corneal sensitivity when switching to ReNu MultiPlus. ReNu MultiPlus was also associated with slightly more corneal staining. Conclusions. ReNu MultiPlus, a biguanide-based contact lens care product, was associated with decreased comfort during midday and end-of-day periods. ReNu MultiPlus was also associated with significant reduction in relative corneal sensitivity compared to Polyquad-based OPTI-FREE Express. Disturbance to normal corneal sensitivity may play a role in contact lens-related dry eye and discomfort. Further investigation is warranted.
Hydrophilic contact lenses and contact lens care products have improved dramatically since their introduction in the early 1960s. However, patient discomfort and dropout continue to plague the contact lens industry. In 2004, nearly as many patients discontinued contact lens wear as were newly fitted with contact lenses-a trend that continues unabated.
Patients wearing hydrophilic lenses often experience contact lens-related discomfort as dryness. 1, 2 For most, discomfort tends to worsen during the day and peaks in the evening hours. 3 Lensrelated discomfort may be sufficiently severe to prompt premature lens removal and reduce maximum wearing time. Proposed causes for contact lens-related discomfort include metabolic depression of corneal function, bulk water loss from hydrophilic lenses, alterations in lens surface wettability, and damage to the lid wiper surfaces of the tarsal conjunctiva. 4 -7 Preservative systems and disinfectants are frequently cited as potential causes of contact lens-related discomfort and dissatisfaction. 8 Intrinsic toxicity of lens care products may be a contributing factor; however, ocular surface disturbance caused by solution toxicity can be obscured by the difficulty of in vivo measurement combined with the cornea's propensity for rapid healing. The cornea may reestablish epithelial integrity before examination shows the consequences of damage to the corneal surface related to the care product. 9 The role of lens care system constituents that condition lens surfaces to enhance and prolong surface wetting has recently garnered renewed attention and may prove an important factor in sustained contact lens comfort. 10 -12 However, overall patient comfort with contact lens wear is likely related to a variety of factors, many of them still obscure.
The importance of normal corneal neural function in maintaining homeostasis of the ocular surface and tear film has recently been described in great detail. 13 Disrupted neural function and diminished corneal sensitivity has been shown to adversely influence tear film integrity and ocular surface health. 14 Transient and occasionally longer-term dry eye is a common complaint after laser in situ keratomileusis as a result of disruption of the corneal neural plexus. 15 Corneal hypoesthesia is a well-recognized complication of contact lens wear. Hypoesthesia is accepted as an essential part of the adaptation mechanism in rigid gas-permeable contact lens wearers and also occurs with soft contact lens wear. 16 -20 Despite the association of contact lens wear and corneal hypoesthesia and the established link between hypoesthesia and dry eye, the relationship of contact lens-related hypoesthesia and dry eye has not been previously investigated.
Hypoesthesia observed with contact lens wear may be related to the lenses themselves or to other factors. Previous reports of biguanide-associated corneal toxicity have described significant superficial corneal staining unaccompanied by discomfort or pho-tophobia when polyhexamethylene biguanide (PHMB)-based ReNu MultiPlus (Bausch & Lomb, Rochester, NY) was used with PureVision silicone hydrogel lenses (Bausch & Lomb) worn on a daily-wear schedule. 21, 22 With the amount of corneal involvement in these reports, the lack of patient discomfort was remarkable. A possible explanation is that ReNu MultiPlus or one of its components impaired corneal sensation in addition to being associated with the observed corneal staining.
To explore the possible relationship between different contact lens care products and corneal sensitivity, a pilot study was conducted. Variables examined included visual analog-based subjective daytime and end-of-day comfort ratings, corneal fluorescein staining, and corneal esthesiometry measurements.
MATERIALS AND METHODS
A crossover study was conducted to assess subjective comfort ratings, superficial corneal staining, and corneal sensitivity among experienced disposable soft contact lens wearers who habitually used OPTI-FREE Express Lasting Comfort No Rub Formula (Alcon Laboratories, Forth Worth, TX) or ReNu MultiPlus. A crossover design was chosen to minimize the influence of extraneous variables. The patient's habitual care product was used as the first treatment period to minimize study cost and complexity. The solution being tested was masked from the investigator.
Key enrollment criteria included absence of ocular disease, previous successful full-time soft disposable (2-week, daily wear, minimum of 8 hours of lens wear per day) contact lens wear for at least 1 year, and habitual use of either of the two test products: OPTI-FREE Express Lasting Comfort No Rub Formula or ReNu MultiPlus.
Participants were randomly selected from the patient population of a suburban specialty contact lens practice. Those who met the entrance criteria were invited to participate in the study. As incentive, participants received two boxes of disposable lenses at the completion of the study. All study-related examinations were provided without additional cost.
All participants were required to provide informed consent, complete a visual analog scale-based questionnaire evaluating habitual midday and end-of-day comfort (0 -100 scale), provide a brief history of their contact lens wear experience, sit for slitlamp examination with and without sodium fluorescein, and allow measurement of corneal sensitivity with a Cochet-Bonnet esthesiometer. The Cochet-Bonnet esthesiometer uses a nylon monofila-ment to quantify relative corneal sensitivity measured on a 0-to-6 scale. Higher numbers represent greater lengths of exposed monofilament and less force applied to the cornea. Thus, higher numbers represent greater amounts of relative corneal sensitivity. All measurements were taken at the corneal center.
Eight patients (16 eyes) were enrolled. Habitual care product use was evenly divided between the two test products; four patients used OPTI-FREE Express and four patients used ReNu MultiPlus. Because the patient's habitual lens care product was used for the first crossover period, the study commenced immediately on the patient's agreement to participate. Corneal sensitivity was measured precisely 10 minutes after lens removal to ensure consistency of data. In addition, all study encounters occurred during the afternoon to eliminate diurnal effects and minimize confounding from length of lens wear.
At the completion of the initial evaluation, a new set of contact lenses was dispensed, and a sufficient supply of the crossover test product was provided to the patient. Participants were instructed to use the test product exclusively for the 2 weeks before the second evaluation. At the second visit, patients were evaluated as previously described.
Changes in corneal sensitivity occurring after crossover were subjected to statistical analysis using an unpaired t test, and overall average sensitivity measures of the two products during both test periods were analyzed using analysis of variance.
RESULTS
Patients completed a visual analog-based scale (VAS) rating of lens comfort at the beginning of each examination. Two time periods were assessed: midday (from 1 to 6 P.M.) and end of day (from 6 P.M. until lens removal). The mean midday comfort score reported by all patients (habitual and crossover) using ReNu MultiPlus was 75.0 compared to 88.75 for those using OPTI-FREE Express ( Table 1 ). By the end of day, comfort ratings decreased appreciably to 57.5 for ReNu users and by a similar amount, to 67.5, for patients using OPTI-FREE Express.
When grouped by habitual lens care product, ReNu MultiPlus users reported midday comfort scores of 88.8 and end-of-day comfort scores of 62.5. In contrast, OPTI-FREE Express users reported average comfort scores of 92.5 midday and 75.0 by the end of the day (Table 1) . There was a four-point comfort advantage for habitual OPTI-FREE Express users during the midday period and a more substantial 12.5-point difference by the end of the day. Habitual and crossover comfort ratings, mean, and both-eye scores are shown. A score of 100 represents greatest comfort.
Patients who switched from ReNu MultiPlus to OPTI-FREE Express reported similar levels of comfort midday (88.75 and 85.0, respectively) and by the end of the day (62.5 and 60.0, respectively). OPTI-FREE Express users who switched to ReNu Multi-Plus reported average comfort scores decreasing from 92.5 to 61.25 midday and 75.0 to 52.5 by the end of the day, respectively. Corneal staining was rated on a 0-to-4 scale as follows: 0, absent staining; 1, trace staining; and 4, severe staining. Staining was not quantified by specific area of the cornea, so staining ratings represent averages for the entire corneal surface. Average both-eye staining for all patients while using ReNu MultiPlus was 0.69 compared to 0.06 for OPTI-FREE Express ( Table 2) . Staining in patients who habitually used ReNu MultiPlus averaged 0.875 for both eyes, whereas OPTI-FREE Express users had an average grade of 0.125 for both eyes. When patients switched care products, those switching to OPTI-FREE Express decreased from 0.875 to 0.125, a decrease of 0.75, whereas habitual OPTI-FREE Express users switching to ReNu MultiPlus increased from 0 staining to an average of 0.5 ( Table 2) .
Corneal sensitivity differences between the two test products were found during both periods of the study. Patients who habitually used ReNu MultiPlus had average scores of 5.00 in the right eye and 4.81 in the left eye (Table 3 ). Habitual OPTI-FREE Express users had scores of 5.44 in the right eye and 5.81 in the left eye ( Table 4 ). Scores of both eyes combined were 4.91 for habitual ReNu users (Table 3 ) and 5.63 for patients using OPTI-FREE Express ( Table 4) .
Esthesiometry scores for all patients (habitual and test groups) using ReNu MultiPlus were 4.81 in the right eye and 4.84 in the left eye, whereas scores for OPTI-FREE Express users were 5.69 in the right eye and 5.75 in the left eye ( Table 5 ). The average sensitivity score for both eyes combined was 4.83 for ReNu MultiPlus compared to 5.72 for OPTI-FREE Express users. Anal-ysis of variance showed significant differences (Pϭ0.0041) in average sensitivity measures of all patients using OPTI-FREE versus those using ReNu.
Patients switching from ReNu MultiPlus to OPTI-FREE Express showed increased corneal sensitivity averaging nearly one full point for both eyes (4.91 vs. 5.81) (Pϭ0.068). Similarly, patients switching from OPTI-FREE Express to ReNu MultiPlus experienced a sensitivity loss of nearly one full point for both eyes (4.75 vs. 5.63) (Pϭ0.107). Although not statistically significant, these suggestive trends were reflective of the small sample size (four in each group) used in this pilot study.
DISCUSSION
The inability of clinicians to accurately and reliably measure subjective contact lens experience or to quantify objective measures that correlate with comfort and patient satisfaction represents a significant clinical dilemma. Without such measures, it is im- possible to scientifically analyze the cause of patient discomfort or accurately evaluate lens and lens care product performance in real world situations. Visual analog scales have been used extensively to measure subjective response to various situations and stimuli. They have been validated for use in eye care and provide a quantifiable measure of subjective patient experience. 23 Despite their ease of application, visual analog scales have not been used extensively in clinical settings other than for Food and Drug Administration clinical or postapproval marketing studies usually sponsored by industry.
Although this pilot study involved a limited patient population, results from visual analog scale testing showed a substantial difference in comfort ratings between patients using OPTI-FREE Express and those using ReNu MultiPlus. Although all patients reported being satisfied with their lenses and care regimens during initial survey, visual analog scale comfort scores reflected considerable discomfort that worsened as the day progressed. Decreases in lens comfort during the afternoon and evening have been previously reported. The differences observed in the current study validate the sensitivity of VAS comfort measurements for detecting clinically significant changes. 24 Comfort differences in favor of OPTI-FREE Express were evident during habitual (first crossover) use. Although differences in exposure times between habitual and crossover-evaluated products complicate interpretation, mean comfort scores showed habitual ReNu users experienced essentially no comfort difference after switching from ReNu MultiPlus to OPTI-FREE Express. In contrast, habitual OPTI-FREE Express users experienced a surprising and clinically significant 20-to 30-point (0 -100 scale) comfort loss after switching to ReNu MutiPlus. This difference was especially notable because of the relatively short exposure time to ReNu MultiPlus among habitual OPTI-FREE Express users and the corresponding decease in measured corneal sensitivity. Among all patients, there was an average 10-point comfort difference between OPTI-FREE Express and ReNu MultiPlus, with OPTI-FREE Express ranking higher than ReNu MultiPlus in this study.
End-of-day discomfort is a likely factor in patient dissatisfaction and dropout. Test data confirmed the trend toward decreased comfort at the end of the day, with an approximate 20-point difference between afternoon and end-of-day comfort. Patients, including those participating in this pilot study, typically describe this discomfort as dryness.
Current thinking regarding the cause of dry eye recognizes the importance of properly functioning corneal sensory nerves and an intact neuronal loop in maintaining ocular surface homeostasis and lacrimal function. This same mechanism may play a role in contact lens wear and may be a factor contributing to the dry eye symptoms and related discomfort that many patients experience.
Decreased corneal sensitivity associated with contact lens wear has been described previously. Other reports have suggested that some lens care products may be responsible for increased levels of end-of-day dryness and overall discomfort. 25 This is the first report to link a biguanide-preserved lens care product with decreased relative corneal sensitivity and a concurrent increase in subjective lens discomfort.
As described previously, a relationship between corneal staining and preservative toxicity has been suggested. Two previous studies reported significant corneal staining in patients who wore PureVision contact lenses and used ReNu MultiPlus on a daily basis. 21, 22 The surface chemistry of the PureVision lens may facilitate high levels of biguanide accumulation from repeated soaking during daily disinfection cycles and the subsequent release of these ingredients onto corneas when the lenses are worn. 26 Despite staining severity expected to cause discomfort or photophobia, patients in these studies remained asymptomatic.
In this study, patients who used ReNu MultiPlus habitually and during the test period showed mild superficial corneal staining. However, as with the aforementioned studies, patients did not complain of discomfort. Possible biguanide-related disturbance to corneal nerve function or transmission may explain the lack of symptoms.
Because of the critical role of an intact neural loop and normal corneal sensation, a neurotoxic or neuropathic effect disrupting corneal sensory nerve function also affords a possible explanation for lens-related dry eye symptoms. A temporary decrease in corneal sensation may significantly reduce lens awareness and discomfort caused by epithelial disturbance. Longer periods of hypoesthesia could possibly affect lacrimal system homeostasis and result in dry eye symptoms. Prolonged hypoesthesia may ultimately lead to symptoms severe enough to prompt discontinuation of lens wear.
CONCLUSIONS
Contact lens discomfort is a problem for a significant percentage of patients wearing soft lenses. It ultimately leads to patient dropout and may have serious short-and long-term practice ramifications. Understanding the fundamental causes of lens discomfort has been complicated by clinicians' inability to correlate patient subjective experience with physical findings. This pilot study explored comfort, corneal sensitivity, and ocular surface integrity in patients using two leading lens care products.
In this study, patients using biguanide-based ReNu MultiPlus were less comfortable during and at the end of the day than were patients who used Polyquad-based OPTI-FREE Express. Patients who used ReNu MultiPlus also had significantly lower corneal sensitivity scores than did patients who used OPTI-FREE Express. Whether this effect is related to the biguanide PHMB, is specific to the ReNu MultiPlus formulation, or is the result of other factors remains unclear and will require further investigation.
The presence of an intact neural loop is essential for the maintenance of a healthy ocular surface. This study suggests that lens care products may disrupt normal ocular surface sensory neural function and thus may play an important and heretofore unrecognized role in lens-related dry eye symptoms and discomfort. Decreases in corneal sensitivity may also explain why patients with clinically significant acute corneal staining remain relatively comfortable despite objectively worrisome physical findings.
It is important to recognize that this is only a preliminary study involving a small sample of experienced contact lens wearers with only partially controlled exposure to the tested care products. The cause and clinical significance of the observed findings remain unclear.
Corneal desensitization induced by lens care products is likely only a small piece of a complex and multifactorial puzzle. Additional research with larger patient populations applying more stringent controls will be necessary to confirm these observations and to better assess the cause and correlation of patient comfort, corneal staining, and lens care product-related corneal hypoesthesia.
